Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Colorcon
Federal Trade Commission
Chinese Patent Office
Cipla

Generated: July 19, 2019

DrugPatentWatch Database Preview

Litigation Details for DEPOMED, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2012)

Try a free trialSee Plans and Pricing

« Back to Dashboard

DEPOMED, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2012)

Docket ➤ Sign Up Date Filed 2012-05-09
Court District Court, D. New Jersey Date Terminated 2014-06-09
Cause 35:145 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties CADILA HEALTHCARE LIMITED; DEPOMED, INC.; ZYDUS PHARMACEUTICALS (USA), INC.
Patents 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,438,927; 7,731,989; 8,192,756; 8,252,332; 8,333,992
Attorneys CHRISTINA LYNN SAVERIANO; ERIC I. ABRAHAM; LEDA DUNN WETTRE; MICHAEL JAMES GESUALDO
Firms Christina Lynn Saveriano; Eric I. Abraham
Link to Docket External link to docket
Small Molecule Drugs cited in DEPOMED, INC. v. ZYDUS PHARMACEUTICALS (USA), INC.
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for DEPOMED, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2013-12-03 158 infringement contentions with respect to U.S. Patent No. 8,333,992 is GRANTED; that Defendants shall serve … 2012 9 June 2014 3:12-cv-02813 830 Patent None District Court, D. New Jersey External link to document
2014-01-28 163 : U.S. Patent No. 6,340,475 (the “ ‘475 patent”), U.S. Patent No. 6,488,962 (the “ ‘962 patent”), U.S….S. Patent No. 6,635,280 (the “ ‘280 patent”), U.S. Patent No. 7,438,927 (the “ ‘927 patent”), U.S. Patent… Patent No. 7,731,989 (the “ ‘989 patent”), U.S. Patent No. 8,192,756 (the “ ‘756 patent”), and U.S. …. Patent No. 8,252,332 (the “ ‘332 patent”). The ‘475 patent and ‘280 patent are directed towards…” 2 See generally, ‘475 patent and ‘280 patent. As explained in these patents, conventional tablets or External link to document
2014-01-28 164 the U.S. Patent No. 6,340,475, U.S. Patent No. 6,488,962, U.S. Patent No. 6,635,280, U.S. Patent No. 7,438,927…,438,927, U.S. Patent No. 7,731,989, U.S. Patent No. 8,192,756, and U.S. Patent No. 8,252,332 shall be… 2012 9 June 2014 3:12-cv-02813 830 Patent None District Court, D. New Jersey External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
McKesson
Chubb
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.